Urinary Stents Market is Anticipated to Surpass US$ 824.69 Million By 2031: Data Analysis by Experts Growth Plus Reports

Newark, New Castle, USA, July 03, 2023 (GLOBE NEWSWIRE) -- As per the latest analysis conducted by Growth Plus Reports, it is anticipated that the worldwide market for urinary stents will experience a Compound Annual Growth Rate (CAGR) of 5.8%, leading to a total revenue of US$ 824.69 million within the projected timeframe of 2023-2031.

We carefully examined the worldwide market for urinary stents, and it is projected to experience substantial growth in the predicted timeframe. These medical devices are inserted into the ureter to eliminate blockages and aid in the smooth passage of urine from the kidney to the bladder.

Latest Updates on the International Urinary Stents Industry:

Get your hands on the complimentary sample report immediately by visiting https://www.growthplusreports.com/inquiry/request-sample/urinary-stents-market/8681.

The extent of the urinary stents market

Factors that Influence and Inhibit the Market: In this section, we will be discussing the various forces that shape and impede the growth of the market.

The main reason behind the increased income in the urinary stents industry is the growing number of older people, individuals with kidney illnesses, and the rising rate of kidney transplant procedures.

Nonetheless, the shortage of skilled healthcare personnel capable of overseeing essential treatment procedures is anticipated to restrict the increase in market earnings.

Product Type Segmentation

The worldwide market for urinary stents is divided into different categories depending on the type of product. These categories include open-ended, close-ended, double pigtail, and multiloop stents. Among these categories, double pigtail stents are the most prevalent and generate the highest revenue share in the global market. This is because they are highly effective in treating a range of urological conditions and offer flexibility and comfort to patients.

Material Type Segmentation

The worldwide urinary stents market is divided into various categories depending on the material used. These include silicon, polyurethane, metal stents, hydrogel, and other materials. Among these, the polyurethane segment takes the lead in the global market, accounting for the highest share of revenue. This is primarily due to its biocompatibility, reduced likelihood of stent migration or displacement, and enhanced patient comfort.

The worldwide market for urinary stents is divided into different categories depending on their purpose, such as treating tumors, kidney transplantation, kidney stones, urinary incontinence, and other conditions. A significant portion of the revenue generated in the global urinary stents market comes from the segment devoted to kidney stone treatment, mainly due to its high occurrence rate.

Categorization Based on User Category

The worldwide market for urinary stents is divided into hospitals, ambulatory surgical centers, and other facilities, depending on the final consumer. The hospital segment holds a significant portion of the total revenue in the global market for urinary stents due to its extensive number of procedures and highly trained healthcare personnel.

The worldwide urinary stents market is divided into different areas, such as North America, Asia Pacific, Latin America, Europe, and the Middle East & Africa. North America has the biggest portion of the market, making it the dominant force globally. The prevalence of kidney stones is significantly high in North America due to various factors related to lifestyle, leading to a greater demand for urinary stents to alleviate blockages in the ureter.

Seeking personalized modifications – https://www.growthplusreports.com/inquiry/customization/urinary-stents-market/8681

Here is a compilation of the leading participants active in the worldwide market for urinary stents:

Growth Plus Reports thoroughly examined the worldwide market for urinary stents and carefully scrutinized the fundamental features of the market, notable investment opportunities, regional growth patterns, projected revenue, competitive players in the market, and the merging and acquisition activities.

Purchase this high-quality research report: https://www.growthplusreports.com/checkout-8681

BENEFITS CONNECTED TO THE DOCUMENT:

Book a phone call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction

Come explore our collection of reports on our website - https://www.growthplusreports.com/report-store

Explore more recent healthcare surveys: Feel free to peruse additional up-to-date healthcare studies: Discover a wider range of current healthcare analyses: Take a look at more recent healthcare research papers: Check out the latest healthcare reports available: Find new healthcare reports to delve into: Explore a variety of recent healthcare studies: Delve deeper into the latest healthcare surveys: Uncover additional healthcare reports to read: Discover more up-to-date healthcare analyses: Browse through a selection of recent healthcare research papers:

Global Forecast 2023-2031 for Combination Antihypertensives Market based on Type (Combining ACE Inhibitors with Calcium Channel blocking agents and ACE inhibitors with thiazides) and Distribution Channel (Hospital Pharmacies and Retail Pharmacies).

Treatment Market for Hydatid Disease by Medication (Mebendazole, Albendazole), Sales Channel (Hospital Pharmacies, Retail Pharmacies) – Worldwide Prospects & Prediction 2023-2031

The market for advanced neuroendocrine tumors is expected to grow steadily over the next decade. This growth will be driven by the increasing prevalence of these tumors and the development of newer and more effective treatments. The market is divided into different drug classes, including platinum coordination complexes and somatostatin analogs. These drugs are used to treat neuroendocrine tumors by targeting specific pathways and suppressing tumor growth. In terms of distribution, hospital pharmacies and retail pharmacies play a crucial role in making these drugs accessible to patients. Hospital pharmacies are often the main source of these medications for patients diagnosed and treated in clinical settings. On the other hand, retail pharmacies cater to patients who may require long-term maintenance therapy or who prefer to obtain their medications closer to home. The global outlook for the high-grade neuroendocrine neoplasms market is positive, with increasing investment in research and development and the introduction of new treatment options. This is likely to drive market growth in the coming years. Overall, the market for high-grade neuroendocrine neoplasms is poised for significant growth, thanks to advancements in drug development and increased awareness and understanding of these rare tumors. The availability of these drugs through various distribution channels ensures improved accessibility for patients worldwide.

Global Outlook and Forecast for the Postoperative Pain Medication Market for the years 2023 to 2031. This market is categorized by the type of drugs used (NSAIDS, Opioids), the method of administration (Oral, Parenteral), and the distribution channels (Hospital Pharmacies, Retail Pharmacies).

The market for mast cell stabilizers is anticipated to experience significant growth during the forecast period from 2023 to 2031. Mast cell stabilizers are commonly used to treat various medical conditions such as mastocytosis, seasonal allergic rhinitis, and perennial allergic conjunctivitis. In terms of distribution channels, hospital pharmacies and retail pharmacies are the key players in the mast cell stabilizers market. These channels play a crucial role in delivering these medications to patients who require them. The global outlook for the mast cell stabilizers market is promising, with an increasing demand for these medications across the globe. Factors such as the rising prevalence of allergies and related conditions and the growing awareness regarding the benefits of mast cell stabilizers are driving the market's growth. Furthermore, advancements in healthcare infrastructure and the availability of a wide range of mast cell stabilizers in different formulations have also contributed to the market's expansion. In conclusion, the mast cell stabilizers market is expected to witness substantial growth in the coming years. With an increasing number of individuals suffering from allergies and related conditions, the demand for mast cell stabilizers is projected to rise. The market's growth will be propelled by factors such as the availability of these medications through various distribution channels and advancements in healthcare infrastructure.

Unleashing the Potential of Innovation in Medical Technology: https://growthplusmedtechroundup.com

Growth Plus Reports is a division of GRG Health, a worldwide healthcare information provider. We take great pride in being affiliated with EPhMRA (European Pharmaceutical Marketing Research Association).

The range of services offered by the Growth Plus portfolio relies on our main abilities in conducting both secondary and primary research, creating market models and predictions, evaluating against benchmarks, analyzing data, and developing strategies. These services are designed to assist clients in building innovative and flexible solutions that will position them for future expansion and triumph.

We were honored by the renowned CEO Magazine as the "Top Healthcare Market Research Company of 2020" for our exceptional innovation.